Expediting drug discovery: recent advances in fast medicinal chemistry--optimization of hits and leads.
This article reviews the literature from January 2004 to January 2006 relating to the use of parallel chemistry compound libraries in drug discovery. Examples of libraries that have yielded active compounds across a range of biological targets are presented, together with synthetic details where relevant. The background of the biological target, and any structure-activity relationship that can be discerned from members of a library series, are also commented upon. A brief discussion of new technological developments in library design and synthesis, and likely future directions for parallel chemistry in the context of drug discovery, is also presented.
Edwards
Paul J
PJ
Department of Medicinal Chemistry, Mechelen, Belgium. Paul.Edwards@glpg.com
Allart
Brigitte
B
Andrews
Martin J I
MJ
Clase
J Andrew
JA
Menet
Christel
C
D000818:Animals; D002626:Chemistry, Pharmaceutical / Q000379:methods* / Q000639:trends; D004791:Enzyme Inhibitors / Q000737:chemistry; D006801:Humans; D004364:Pharmaceutical Preparations / Q000737:chemistry*
D004791:Enzyme Inhibitors; D004364:Pharmaceutical Preparations